Question 1

What specific medications will I be taking in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. clinical trial (NCT00326963). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this new treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. clinical trial (NCT00326963). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. clinical trial (NCT00326963). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. clinical trial (NCT00326963). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. clinical trial (NCT00326963). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will I be on the study treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. clinical trial (NCT00326963). Contact the study team or your healthcare provider for specific answers.

What this study is about